Literature DB >> 19896432

Preview. Mutant CEBPA: Priming Stem Cells for Myeloid Leukemogenesis.

Tim C P Somervaille1, Michael L Cleary.   

Abstract

In a recent study published in Cancer Cell, Bereshchenko and colleagues (2009) report a knockin mouse model that represents the most frequently occurring biallelic combination of CEBPA mutations found in human acute myeloid leukemia.

Entities:  

Year:  2009        PMID： 19896432     DOI： 10.1016/j.stem.2009.10.008

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  3 in total

1.  Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia.

Authors:  Iris H I M Hollink; Marry M van den Heuvel-Eibrink; Susan T C J M Arentsen-Peters; Martin Zimmermann; Justine K Peeters; Peter J M Valk; Brian V Balgobind; Edwin Sonneveld; Gertjan J L Kaspers; Eveline S J M de Bont; Jan Trka; Andre Baruchel; Ursula Creutzig; Rob Pieters; Dirk Reinhardt; C Michel Zwaan
Journal:  Haematologica       Date:  2010-12-06       Impact factor: 9.941

2.  Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications.

Authors:  Carolina Molina Garay; Karol Carrillo Sánchez; Luis Leonardo Flores Lagunes; Marco Jiménez Olivares; Anallely Muñoz Rivas; Beatríz Eugenia Villegas Torres; Hilario Flores Aguilar; Juan Carlos Núñez Enríquez; Elva Jiménez Hernández; Vilma Carolina Bekker Méndez; José Refugio Torres Nava; Janet Flores Lujano; Jorge Alfonso Martín Trejo; Minerva Mata Rocha; Aurora Medina Sansón; Laura Eugenia Espinoza Hernández; José Gabriel Peñaloza Gonzalez; Rosa Martha Espinosa Elizondo; Luz Victoria Flores Villegas; Raquel Amador Sanchez; María Luisa Pérez Saldívar; Omar Alejandro Sepúlveda Robles; Haydeé Rosas Vargas; Silvia Jiménez Morales; Patricia Galindo Delgado; Juan Manuel Mejía Aranguré; Carmen Alaez Verson
Journal:  Front Pediatr       Date:  2022-07-11       Impact factor: 3.569

3.  Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.

Authors:  H Matsuo; M Kajihara; D Tomizawa; T Watanabe; A M Saito; J Fujimoto; K Horibe; K Kodama; M Tokumasu; H Itoh; H Nakayama; A Kinoshita; T Taga; A Tawa; T Taki; S Tanaka; S Adachi
Journal:  Blood Cancer J       Date:  2014-07-11       Impact factor: 11.037
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.